
GEHC Stock Forecast & Price Target
GEHC Analyst Ratings
Bulls say
GE HealthCare Techs is expected to show 3.4% organic revenue growth in FY26, driven by strong demand for imaging and ultrasound equipment, recurring revenue streams such as servicing and pharmaceutical diagnostics, and continued international expansion. The company has a solid financial outlook with an estimated EPS of $4.84 and an EBIT margin of 15.4% - 15.7%. Additionally, GE HealthCare's recent M&A activity and new product launches are expected to drive future revenue growth.
Bears say
GE HealthCare Techs is a leading medical technology firm, with a diverse geographical presence and strong recurring revenue. However, the company has faced challenges from trade wars and inflationary dynamics, leading to underperformance post-spin. While there are opportunities for growth and margin improvements, ongoing macroeconomic challenges and competition in key markets could impact future performance. Investors should also keep an eye on potential disruptions to manufacturing and supply chain.
This aggregate rating is based on analysts' research of GE HealthCare Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.
GEHC Analyst Forecast & Price Prediction
Start investing in GEHC
Order type
Buy in
Order amount
Est. shares
0 shares